BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15897934)

  • 1. Cancer treatment-induced bone loss in patients with breast or prostate cancer.
    Maxwell C; Viale PH
    Oncol Nurs Forum; 2005 May; 32(3):589-603. PubMed ID: 15897934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-treatment-induced bone loss, part 2.
    Michaud LB; Goodin S
    Am J Health Syst Pharm; 2006 Mar; 63(6):534-46. PubMed ID: 16522890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-treatment-induced bone loss, part 1.
    Michaud LB; Goodin S
    Am J Health Syst Pharm; 2006 Mar; 63(5):419-30. PubMed ID: 16484516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
    Brufsky AM
    Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer Treatment-Induced Bone Loss(CTIBL)].
    Fukumoto S; Matsumoto T
    Gan To Kagaku Ryoho; 2018 Dec; 45(12):1685-1689. PubMed ID: 30587719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer treatment-induced bone loss in breast and prostate cancer.
    Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
    J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer treatment-induced bone loss. Treatment for breast cancer].
    Yamada K; Kohno N
    Clin Calcium; 2008 Apr; 18(4):507-17. PubMed ID: 18379033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiresorptive therapy in the management of cancer treatment-induced bone loss.
    Garg A; Leitzel K; Ali S; Lipton A
    Curr Osteoporos Rep; 2015 Apr; 13(2):73-7. PubMed ID: 25575469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL].
    Takahashi S
    Clin Calcium; 2011 Mar; 21(3):447-53. PubMed ID: 21358067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)].
    Takahashi S
    Clin Calcium; 2011 Aug; 21(8):1239-47. PubMed ID: 21814031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward new horizons: the future of bisphosphonate therapy.
    Lipton A
    Oncologist; 2004; 9 Suppl 4():38-47. PubMed ID: 15459428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
    Brufsky A
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
    Higano CS
    Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer.
    Michaud LB
    Am J Health Syst Pharm; 2010 Apr; 67(7 Suppl 3):S20-30; quiz S31-3. PubMed ID: 20332495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and implications of cancer treatment-induced bone loss.
    Theriault RL
    Oncology (Williston Park); 2004 May; 18(5 Suppl 3):11-5. PubMed ID: 15202582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal health in breast cancer survivors.
    Bruyère O; Bergmann P; Cavalier E; Gielen E; Goemaere S; Kaufman JM; Rozenberg S; Body JJ
    Maturitas; 2017 Nov; 105():78-82. PubMed ID: 28838807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody.
    von Moos R; Costa L; Gonzalez-Suarez E; Terpos E; Niepel D; Body JJ
    Cancer Treat Rev; 2019 Jun; 76():57-67. PubMed ID: 31136850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy with bone-targeted agents.
    Wilson C; Coleman RE
    Curr Opin Support Palliat Care; 2011 Sep; 5(3):241-50. PubMed ID: 21785355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone loss in patients with breast or prostate cancer.
    Hu MI; Gagel RF; Jimenez C
    Curr Osteoporos Rep; 2007 Dec; 5(4):170-8. PubMed ID: 18430392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term implications of bone loss in breast cancer.
    Aapro MS
    Breast; 2004 Dec; 13 Suppl 1():S29-37. PubMed ID: 15585380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.